| Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2310016C
16Rik |  |
NM_027127 |
RIKEN cDNA 2310016C16 gene (2310016C16Rik), mRNA [NM_027127] |
KLA | .94 |
1.03 |
1.06 |
1.07 |
.99 |
1.05 |
.96 |
| ATP | .97 |
1.01 |
1.01 |
1.04 |
1.01 |
1.07 |
1.05 |
| KLA/ATP | 1.04 |
1.08 |
1.09 |
1.01 |
1.03 |
1.02 |
.98 |
|
2810405K
02Rik |  |
NM_025582 |
RIKEN cDNA 2810405K02 gene (2810405K02Rik), mRNA [NM_025582] |
KLA | .77 |
.68 |
.61 |
.70 |
.71 |
1.04 |
1.22 |
| ATP | .88 |
.87 |
1.16 |
1.24 |
1.07 |
.64 |
.92 |
| KLA/ATP | .65 |
.74 |
.89 |
.88 |
.88 |
.58 |
.54 |
|
AK085608
|  |
AK085608 |
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630046G10 product:unclassifiable, full insert sequence. [AK085608] |
KLA | .89 |
.96 |
1.01 |
1.03 |
.96 |
.98 |
1.07 |
| ATP | 1.03 |
1.00 |
.96 |
1.01 |
1.05 |
1.04 |
1.00 |
| KLA/ATP | 1.00 |
1.00 |
.99 |
1.04 |
1.01 |
.99 |
1.00 |
|
| Alox12 |  |
NM_007440 |
arachidonate 12-lipoxygenase (Alox12), mRNA [NM_007440] |
KLA | 1.35 |
1.36 |
1.42 |
1.25 |
1.25 |
1.13 |
1.15 |
| ATP | 1.05 |
1.01 |
1.03 |
1.04 |
1.04 |
1.42 |
1.20 |
| KLA/ATP | 1.36 |
1.29 |
1.23 |
1.26 |
1.24 |
1.31 |
1.80 |
|
| Alox12b |  |
NM_009659 |
arachidonate 12-lipoxygenase, 12R type (Alox12b), mRNA [NM_009659] |
KLA | 1.09 |
1.09 |
1.18 |
1.15 |
1.14 |
1.28 |
1.26 |
| ATP | .99 |
.92 |
1.09 |
1.07 |
1.03 |
1.10 |
1.29 |
| KLA/ATP | 1.16 |
1.20 |
1.27 |
1.30 |
1.21 |
1.19 |
1.30 |
|
| Alox12e |  |
NM_145684 |
arachidonate lipoxygenase, epidermal (Alox12e), mRNA [NM_145684] |
KLA | .97 |
.99 |
1.05 |
.94 |
.99 |
1.01 |
.96 |
| ATP | 1.00 |
.97 |
1.01 |
.98 |
1.01 |
1.01 |
.94 |
| KLA/ATP | .99 |
.92 |
.91 |
.98 |
.95 |
.95 |
.95 |
|
| Alox15 |  |
NM_009660 |
arachidonate 15-lipoxygenase (Alox15), mRNA [NM_009660] |
KLA | 1.02 |
.93 |
.98 |
.96 |
.98 |
.95 |
.87 |
| ATP | .92 |
.95 |
1.09 |
1.01 |
.98 |
1.00 |
.97 |
| KLA/ATP | .97 |
.95 |
.98 |
.94 |
.98 |
.97 |
.92 |
|
| Alox5 |  |
NM_009662 |
arachidonate 5-lipoxygenase (Alox5), mRNA [NM_009662] |
KLA | .83 |
.87 |
.88 |
.87 |
.71 |
.58 |
.21 |
| ATP | 1.03 |
1.03 |
1.14 |
1.21 |
.93 |
.55 |
.41 |
| KLA/ATP | .86 |
.85 |
.90 |
.97 |
.84 |
.61 |
.24 |
|
| Alox8 |  |
NM_009661 |
arachidonate 8-lipoxygenase (Alox8), mRNA [NM_009661] |
KLA | 1.02 |
.99 |
1.01 |
1.00 |
.99 |
1.06 |
.95 |
| ATP | 1.04 |
.99 |
.86 |
.96 |
.92 |
1.02 |
.95 |
| KLA/ATP | .98 |
.99 |
1.03 |
1.00 |
.98 |
.91 |
.90 |
|
| Cbr1 |  |
U31966 |
carbonyl reductase (Cbr1) mRNA, complete cds. [U31966] |
KLA | .79 |
.82 |
.80 |
.76 |
.69 |
.91 |
.89 |
| ATP | .95 |
.90 |
1.24 |
1.29 |
1.39 |
1.58 |
2.18 |
| KLA/ATP | .82 |
.79 |
1.22 |
1.01 |
1.41 |
1.76 |
1.89 |
|
| Cbr2 |  |
NM_007621 |
carbonyl reductase 2 (Cbr2), mRNA [NM_007621] |
KLA | 1.04 |
1.02 |
.94 |
1.08 |
1.10 |
1.15 |
.31 |
| ATP | 1.04 |
.97 |
1.18 |
1.27 |
1.37 |
1.11 |
.44 |
| KLA/ATP | 1.06 |
1.09 |
1.32 |
1.27 |
1.33 |
1.00 |
.41 |
|
| Cbr3 |  |
NM_173047 |
carbonyl reductase 3 (Cbr3), mRNA [NM_173047] |
KLA | .37 |
.38 |
.29 |
.33 |
.21 |
.23 |
.42 |
| ATP | .97 |
.84 |
1.07 |
.78 |
1.72 |
6.22 |
1.28 |
| KLA/ATP | .38 |
.35 |
.52 |
.33 |
1.22 |
2.51 |
1.25 |
|
| Cyp2b10 |  |
NM_009999 |
cytochrome P450, family 2, subfamily b, polypeptide 10 (Cyp2b10), transcript variant 2, mRNA [NM_009999] |
KLA | .98 |
1.03 |
.97 |
1.02 |
1.02 |
.97 |
1.03 |
| ATP | 1.03 |
.99 |
1.02 |
1.02 |
.98 |
1.02 |
.99 |
| KLA/ATP | 1.04 |
1.00 |
1.02 |
.93 |
.97 |
.93 |
.91 |
|
| Cyp2b13 |  |
NM_007813 |
cytochrome P450, family 2, subfamily b, polypeptide 13 (Cyp2b13), mRNA [NM_007813] |
KLA | .99 |
1.02 |
1.00 |
1.06 |
1.05 |
1.03 |
.99 |
| ATP | .96 |
.96 |
.96 |
.98 |
.99 |
.95 |
.98 |
| KLA/ATP | 1.00 |
1.03 |
1.04 |
1.02 |
1.01 |
1.06 |
.99 |
|
| Cyp2b19 |  |
AK029227 |
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831430P04 product:cytochrome P450, 2b19, full insert sequence. [AK029227] |
KLA | .96 |
.98 |
1.02 |
1.09 |
1.06 |
1.00 |
1.08 |
| ATP | 1.02 |
1.06 |
.91 |
1.05 |
1.00 |
.97 |
.95 |
| KLA/ATP | .99 |
.93 |
.96 |
1.03 |
1.00 |
1.04 |
1.00 |
|
| Cyp2b19 | |
NM_007814 |
cytochrome P450, family 2, subfamily b, polypeptide 19 (Cyp2b19), mRNA [NM_007814] |
KLA | 1.14 |
1.20 |
1.18 |
1.17 |
1.17 |
1.21 |
1.14 |
| ATP | .96 |
1.01 |
1.11 |
1.08 |
.99 |
1.08 |
1.10 |
| KLA/ATP | 1.09 |
1.05 |
1.17 |
1.16 |
1.16 |
1.10 |
1.07 |
|
| Cyp2b23 |  |
NM_001081148 |
cytochrome P450, family 2, subfamily b, polypeptide 23 (Cyp2b23), mRNA [NM_001081148] |
KLA | 1.09 |
.96 |
1.01 |
.95 |
.97 |
1.01 |
.92 |
| ATP | .97 |
1.00 |
.92 |
.92 |
.98 |
.97 |
.94 |
| KLA/ATP | 1.01 |
1.02 |
1.03 |
.94 |
.94 |
.93 |
.97 |
|
| Cyp2b9 |  |
NM_010000 |
cytochrome P450, family 2, subfamily b, polypeptide 9 (Cyp2b9), mRNA [NM_010000] |
KLA | .99 |
1.00 |
1.02 |
1.01 |
1.03 |
.98 |
1.03 |
| ATP | 1.01 |
.98 |
.97 |
.98 |
1.01 |
.96 |
.98 |
| KLA/ATP | 1.00 |
1.04 |
.94 |
1.04 |
1.02 |
1.03 |
.99 |
|
| Cyp2c29 |  |
NM_007815 |
cytochrome P450, family 2, subfamily c, polypeptide 29 (Cyp2c29), mRNA [NM_007815] |
KLA | 1.01 |
.95 |
1.06 |
1.12 |
1.01 |
1.02 |
1.12 |
| ATP | 1.03 |
1.02 |
1.01 |
1.06 |
.98 |
.98 |
.96 |
| KLA/ATP | 1.09 |
1.14 |
1.02 |
.98 |
.99 |
.98 |
.98 |
|
| Cyp2c37 |  |
NM_010001 |
cytochrome P450, family 2. subfamily c, polypeptide 37 (Cyp2c37), mRNA [NM_010001] |
KLA | 1.27 |
1.43 |
1.64 |
1.52 |
1.65 |
1.43 |
1.45 |
| ATP | .99 |
.96 |
1.03 |
1.13 |
1.10 |
1.03 |
1.27 |
| KLA/ATP | 1.37 |
1.49 |
1.22 |
1.46 |
1.16 |
1.12 |
1.24 |
|
| Cyp2c38 |  |
NM_010002 |
cytochrome P450, family 2, subfamily c, polypeptide 38 (Cyp2c38), mRNA [NM_010002] |
KLA | 1.01 |
1.06 |
.98 |
.96 |
1.07 |
.98 |
.97 |
| ATP | 1.01 |
1.09 |
1.04 |
.98 |
1.00 |
1.03 |
.98 |
| KLA/ATP | 1.03 |
.98 |
1.03 |
1.04 |
1.00 |
1.00 |
1.01 |
|
| Cyp2c39 |  |
NM_010003 |
cytochrome P450, family 2, subfamily c, polypeptide 39 (Cyp2c39), mRNA [NM_010003] |
KLA | 1.04 |
1.01 |
.97 |
1.00 |
.99 |
1.01 |
.98 |
| ATP | 1.04 |
1.07 |
.95 |
1.00 |
.96 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
1.01 |
1.02 |
1.01 |
1.05 |
1.05 |
.99 |
|
| Cyp2c40 |  |
NM_010004 |
cytochrome P450, family 2, subfamily c, polypeptide 40 (Cyp2c40), mRNA [NM_010004] |
KLA | .96 |
1.06 |
1.05 |
1.03 |
.99 |
1.01 |
1.02 |
| ATP | .96 |
1.01 |
1.02 |
.97 |
1.01 |
1.02 |
.99 |
| KLA/ATP | 1.06 |
1.03 |
1.04 |
.98 |
1.05 |
1.01 |
.97 |
|
| Cyp2c44 |  |
NM_001001446 |
cytochrome P450, family 2, subfamily c, polypeptide 44 (Cyp2c44), mRNA [NM_001001446] |
KLA | .98 |
1.04 |
.93 |
1.05 |
1.01 |
.93 |
.94 |
| ATP | 1.02 |
1.01 |
1.01 |
1.04 |
1.02 |
1.02 |
1.00 |
| KLA/ATP | .93 |
.95 |
1.00 |
1.05 |
1.07 |
1.01 |
1.01 |
|
| Cyp2c54 |  |
NM_206537 |
cytochrome P450, family 2, subfamily c, polypeptide 54 (Cyp2c54), mRNA [NM_206537] |
KLA | .98 |
.99 |
1.04 |
.97 |
1.06 |
1.03 |
1.04 |
| ATP | .99 |
.98 |
1.10 |
1.03 |
1.03 |
.98 |
1.03 |
| KLA/ATP | 1.02 |
1.04 |
.89 |
.98 |
.99 |
.93 |
.99 |
|
| Cyp2c55 |  |
NM_028089 |
cytochrome P450, family 2, subfamily c, polypeptide 55 (Cyp2c55), mRNA [NM_028089] |
KLA | .97 |
1.02 |
1.01 |
.99 |
.99 |
1.00 |
.94 |
| ATP | 1.04 |
.98 |
1.09 |
.97 |
1.05 |
.99 |
1.06 |
| KLA/ATP | 1.04 |
1.01 |
1.15 |
1.03 |
1.05 |
1.05 |
1.09 |
|
| Cyp2c65 |  |
AK008688 |
adult male stomach cDNA, RIKEN full-length enriched library, clone:2210009K14 product:similar to CYTOCHROME P450 2C18 (EC 1.14.14.1) (CYPIIC18) (P450-6B [AK008688] |
KLA | .95 |
.97 |
1.02 |
1.00 |
.97 |
1.10 |
1.04 |
| ATP | .98 |
1.05 |
1.00 |
1.10 |
.98 |
.99 |
1.03 |
| KLA/ATP | .96 |
.97 |
.99 |
1.01 |
1.03 |
1.04 |
1.03 |
|
| Cyp2c66 |  |
NM_001011707 |
cytochrome P450, family 2, subfamily c, polypeptide 66 (Cyp2c66), mRNA [NM_001011707] |
KLA | 1.03 |
1.04 |
.99 |
1.00 |
1.06 |
1.11 |
1.01 |
| ATP | .97 |
1.01 |
1.03 |
1.00 |
.98 |
1.03 |
1.04 |
| KLA/ATP | 1.08 |
.97 |
1.15 |
1.02 |
1.04 |
1.06 |
1.08 |
|
| Cyp2c70 |  |
NM_145499 |
cytochrome P450, family 2, subfamily c, polypeptide 70 (Cyp2c70), mRNA [NM_145499] |
KLA | 1.05 |
.94 |
.95 |
.86 |
1.06 |
.96 |
.99 |
| ATP | 1.01 |
.98 |
.69 |
.69 |
.97 |
.87 |
1.09 |
| KLA/ATP | 1.00 |
.97 |
.74 |
.74 |
.81 |
.86 |
1.17 |
|
| Cyp2e1 |  |
NM_021282 |
cytochrome P450, family 2, subfamily e, polypeptide 1 (Cyp2e1), mRNA [NM_021282] |
KLA | .99 |
1.03 |
1.05 |
1.01 |
.99 |
1.06 |
1.00 |
| ATP | .96 |
.93 |
.98 |
1.05 |
1.01 |
1.03 |
1.10 |
| KLA/ATP | 1.04 |
.99 |
1.02 |
1.00 |
1.05 |
1.04 |
.99 |
|
| Cyp2j11 |  |
NM_001004141 |
cytochrome P450, family 2, subfamily j, polypeptide 11 (Cyp2j11), mRNA [NM_001004141] |
KLA | .95 |
1.02 |
1.07 |
.95 |
.95 |
.92 |
.83 |
| ATP | .95 |
1.02 |
1.05 |
.93 |
.92 |
.90 |
1.00 |
| KLA/ATP | 1.05 |
.96 |
1.00 |
.97 |
.90 |
.82 |
.86 |
|
| Cyp2j13 |  |
NM_145548 |
cytochrome P450, family 2, subfamily j, polypeptide 13 (Cyp2j13), mRNA [NM_145548] |
KLA | 1.01 |
.99 |
.98 |
1.00 |
.98 |
.96 |
.92 |
| ATP | .99 |
1.03 |
1.01 |
.98 |
.95 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.03 |
1.02 |
1.03 |
.96 |
.95 |
.96 |
|
| Cyp2j5 |  |
NM_010007 |
cytochrome P450, family 2, subfamily j, polypeptide 5 (Cyp2j5), mRNA [NM_010007] |
KLA | 1.00 |
.99 |
1.05 |
1.01 |
1.00 |
1.06 |
1.06 |
| ATP | .99 |
1.00 |
1.03 |
1.09 |
1.00 |
1.03 |
1.01 |
| KLA/ATP | 1.03 |
.98 |
1.09 |
1.11 |
1.06 |
1.09 |
1.01 |
|
| Cyp2j9 |  |
NM_028979 |
cytochrome P450, family 2, subfamily j, polypeptide 9 (Cyp2j9), mRNA [NM_028979] |
KLA | .84 |
.88 |
.97 |
.91 |
.75 |
.66 |
.66 |
| ATP | 1.10 |
.98 |
.99 |
.92 |
.90 |
.73 |
.64 |
| KLA/ATP | .88 |
.95 |
.93 |
.86 |
.80 |
.78 |
.59 |
|
| Cyp2u1 |  |
AK142740 |
16 days neonate heart cDNA, RIKEN full-length enriched library, clone:D830039I11 product:cytochrome P450, family 2, subfamily u, polypeptide 1, full insert sequence [AK142740] |
KLA | .85 |
.89 |
.83 |
.86 |
.76 |
.80 |
.94 |
| ATP | .97 |
1.09 |
.99 |
.90 |
.84 |
.87 |
.96 |
| KLA/ATP | .82 |
.88 |
.85 |
.80 |
.79 |
.81 |
.89 |
|
| Cyp4a10 |  |
NM_010011 |
cytochrome P450, family 4, subfamily a, polypeptide 10 (Cyp4a10), mRNA [NM_010011] |
KLA | 1.14 |
1.13 |
1.13 |
1.13 |
1.15 |
1.12 |
1.06 |
| ATP | 1.02 |
1.01 |
1.09 |
1.03 |
1.10 |
1.11 |
1.00 |
| KLA/ATP | 1.09 |
1.11 |
1.36 |
1.23 |
1.25 |
1.09 |
1.02 |
|
| Cyp4a10 | |
X71478 |
gb|M.musculus Cyp4a-10 mRNA. [X71478] |
KLA | .94 |
.97 |
.93 |
1.01 |
1.01 |
1.09 |
1.26 |
| ATP | .96 |
1.07 |
1.04 |
1.18 |
.88 |
.77 |
1.18 |
| KLA/ATP | 1.00 |
.99 |
.98 |
.98 |
.84 |
.80 |
1.24 |
|
Cyp4a12a
|  |
NM_177406 |
cytochrome P450, family 4, subfamily a, polypeptide 12a (Cyp4a12a), mRNA [NM_177406] |
KLA | 1.08 |
1.04 |
1.02 |
1.06 |
.98 |
1.05 |
1.05 |
| ATP | .98 |
1.00 |
1.10 |
.99 |
.96 |
1.04 |
.98 |
| KLA/ATP | 1.07 |
1.05 |
1.11 |
.96 |
1.06 |
1.02 |
.97 |
|
Cyp4a12b
|  |
NM_172306 |
cytochrome P450, family 4, subfamily a, polypeptide 12B (Cyp4a12b), mRNA [NM_172306] |
KLA | 1.03 |
1.05 |
.95 |
.99 |
.94 |
1.02 |
1.12 |
| ATP | .93 |
.99 |
.95 |
1.00 |
.93 |
.95 |
1.01 |
| KLA/ATP | .98 |
1.01 |
1.09 |
1.00 |
.90 |
.91 |
.93 |
|
| Cyp4a14 |  |
NM_007822 |
cytochrome P450, family 4, subfamily a, polypeptide 14 (Cyp4a14), mRNA [NM_007822] |
KLA | .99 |
1.00 |
1.00 |
.97 |
.96 |
.97 |
1.01 |
| ATP | .95 |
.95 |
.93 |
.90 |
.93 |
.99 |
1.03 |
| KLA/ATP | .97 |
.99 |
1.04 |
.93 |
.95 |
.96 |
.97 |
|
| Cyp4a29 |  |
NM_001100183 |
cytochrome P450, family 4, subfamily a, polypeptide 29 (Cyp4a29), mRNA [NM_001100183] |
KLA | .94 |
.98 |
1.04 |
1.00 |
.98 |
1.06 |
1.03 |
| ATP | 1.01 |
1.02 |
1.03 |
1.02 |
1.01 |
1.02 |
.97 |
| KLA/ATP | 1.05 |
1.09 |
1.03 |
1.03 |
.97 |
1.02 |
.91 |
|
| Cyp4a31 |  |
NM_201640 |
cytochrome P450, family 4, subfamily a, polypeptide 31 (Cyp4a31), mRNA [NM_201640] |
KLA | 1.14 |
.99 |
1.00 |
.98 |
1.06 |
1.03 |
.96 |
| ATP | 1.01 |
1.05 |
1.04 |
.91 |
.98 |
.99 |
.99 |
| KLA/ATP | .99 |
1.03 |
1.04 |
.99 |
.95 |
.97 |
1.06 |
|
| Cyp4f13 |  |
NM_130882 |
cytochrome P450, family 4, subfamily f, polypeptide 13 (Cyp4f13), mRNA [NM_130882] |
KLA | .96 |
.94 |
1.02 |
.99 |
1.11 |
1.26 |
1.34 |
| ATP | 1.03 |
1.05 |
1.03 |
1.24 |
.88 |
.61 |
.88 |
| KLA/ATP | 1.05 |
1.02 |
1.01 |
1.13 |
.87 |
.75 |
1.20 |
|
| Cyp4f14 |  |
NM_022434 |
cytochrome P450, family 4, subfamily f, polypeptide 14 (Cyp4f14), mRNA [NM_022434] |
KLA | 1.06 |
1.01 |
1.08 |
1.04 |
1.03 |
1.00 |
1.05 |
| ATP | 1.07 |
.94 |
.92 |
1.01 |
1.00 |
.97 |
1.06 |
| KLA/ATP | 1.04 |
.99 |
.82 |
.95 |
.93 |
1.05 |
1.11 |
|
| Cyp4f15 |  |
NM_134127 |
cytochrome P450, family 4, subfamily f, polypeptide 15 (Cyp4f15), mRNA [NM_134127] |
KLA | .98 |
.95 |
1.05 |
1.02 |
.98 |
.96 |
1.05 |
| ATP | 1.01 |
.98 |
1.09 |
1.03 |
1.03 |
1.02 |
1.08 |
| KLA/ATP | 1.02 |
.97 |
.98 |
.98 |
.99 |
1.01 |
1.02 |
|
| Cyp4f16 |  |
NM_024442 |
cytochrome P450, family 4, subfamily f, polypeptide 16 (Cyp4f16), mRNA [NM_024442] |
KLA | .87 |
.91 |
.89 |
.94 |
1.01 |
1.03 |
1.34 |
| ATP | 1.12 |
1.16 |
1.07 |
1.15 |
.88 |
.61 |
1.00 |
| KLA/ATP | .95 |
1.05 |
.92 |
.98 |
.72 |
.68 |
1.02 |
|
| Cyp4f18 |  |
NM_024444 |
cytochrome P450, family 4, subfamily f, polypeptide 18 (Cyp4f18), mRNA [NM_024444] |
KLA | 1.03 |
1.06 |
1.06 |
1.15 |
1.13 |
1.14 |
1.29 |
| ATP | 1.00 |
1.06 |
1.16 |
1.36 |
1.36 |
1.11 |
1.06 |
| KLA/ATP | 1.03 |
1.11 |
1.14 |
1.22 |
1.20 |
1.93 |
2.92 |
|
| Cyp4f39 |  |
NM_177307 |
cytochrome P450, family 4, subfamily f, polypeptide 39 (Cyp4f39), mRNA [NM_177307] |
KLA | .96 |
1.00 |
.97 |
1.06 |
1.03 |
1.09 |
1.07 |
| ATP | .99 |
.95 |
.93 |
1.05 |
.81 |
.86 |
1.24 |
| KLA/ATP | .97 |
.88 |
.84 |
.91 |
.89 |
.96 |
1.07 |
|
| Ephx2 |  |
NM_007940 |
epoxide hydrolase 2, cytoplasmic (Ephx2), mRNA [NM_007940] |
KLA | 1.03 |
.96 |
.96 |
1.03 |
1.02 |
1.03 |
.87 |
| ATP | .97 |
.95 |
1.09 |
1.08 |
1.00 |
1.06 |
.96 |
| KLA/ATP | .97 |
1.03 |
1.07 |
1.09 |
1.13 |
.98 |
1.00 |
|
| Ggt1 |  |
NM_008116 |
gamma-glutamyltransferase 1 (Ggt1), mRNA [NM_008116] |
KLA | 1.03 |
1.00 |
1.00 |
1.05 |
1.00 |
1.02 |
1.02 |
| ATP | 1.00 |
1.00 |
.96 |
1.00 |
1.03 |
1.02 |
.99 |
| KLA/ATP | .98 |
.99 |
1.04 |
1.00 |
.99 |
.98 |
.98 |
|
| Ggt5 |  |
NM_011820 |
gamma-glutamyltransferase 5 (Ggt5), mRNA [NM_011820] |
KLA | .89 |
.91 |
.92 |
.89 |
.86 |
.79 |
.58 |
| ATP | 1.00 |
1.03 |
.93 |
.97 |
.84 |
.80 |
.59 |
| KLA/ATP | 1.00 |
.92 |
.93 |
.98 |
.83 |
.79 |
.68 |
|
| Ggt6 |  |
NM_027819 |
gamma-glutamyltransferase 6 (Ggt6), mRNA [NM_027819] |
KLA | 1.03 |
.90 |
.98 |
1.07 |
1.00 |
1.02 |
.98 |
| ATP | 1.02 |
1.07 |
.90 |
1.02 |
1.03 |
1.03 |
.94 |
| KLA/ATP | .99 |
1.04 |
.98 |
.97 |
1.02 |
1.01 |
.96 |
|
| Ggt7 |  |
NM_144786 |
gamma-glutamyltransferase 7 (Ggt7), mRNA [NM_144786] |
KLA | .96 |
1.03 |
.97 |
1.01 |
1.00 |
.98 |
.89 |
| ATP | 1.03 |
1.02 |
1.01 |
.92 |
.94 |
.97 |
1.00 |
| KLA/ATP | .98 |
.95 |
1.05 |
.89 |
.92 |
.94 |
.94 |
|
| Gpx1 |  |
NM_008160 |
glutathione peroxidase 1 (Gpx1), mRNA [NM_008160] |
KLA | .63 |
.68 |
.67 |
.51 |
.52 |
.48 |
.64 |
| ATP | 1.02 |
1.01 |
.85 |
.91 |
.66 |
.41 |
.97 |
| KLA/ATP | .76 |
.73 |
.47 |
.61 |
.45 |
.39 |
.70 |
|
| Gpx2 |  |
NM_030677 |
glutathione peroxidase 2 (Gpx2), mRNA [NM_030677] |
KLA | .69 |
.71 |
.59 |
.69 |
.72 |
.69 |
.69 |
| ATP | 1.08 |
1.10 |
.74 |
.79 |
.77 |
.66 |
.64 |
| KLA/ATP | .70 |
.65 |
.69 |
.74 |
.78 |
.76 |
.53 |
|
| Gpx3 |  |
NM_008161 |
glutathione peroxidase 3 (Gpx3), transcript variant 2, mRNA [NM_008161] |
KLA | 1.14 |
1.14 |
1.20 |
1.09 |
1.07 |
.85 |
.50 |
| ATP | 1.15 |
1.15 |
1.00 |
1.84 |
1.10 |
.96 |
.62 |
| KLA/ATP | 1.14 |
1.17 |
.93 |
1.48 |
.90 |
.99 |
.64 |
|
| Gpx5 |  |
X53780 |
gb|Mouse mRNA for 24kDa major androgen regulated protein, arMEP24. [X53780] |
KLA | .95 |
1.02 |
.99 |
.99 |
.97 |
1.06 |
.98 |
| ATP | 1.04 |
.94 |
.96 |
1.05 |
1.02 |
1.01 |
.98 |
| KLA/ATP | .98 |
1.00 |
.98 |
.93 |
1.00 |
1.07 |
.99 |
|
| Gpx6 |  |
NM_145451 |
glutathione peroxidase 6 (Gpx6), mRNA [NM_145451] |
KLA | 1.00 |
1.05 |
1.02 |
.99 |
1.04 |
1.03 |
.94 |
| ATP | .98 |
1.03 |
1.04 |
.91 |
.92 |
1.03 |
1.05 |
| KLA/ATP | .99 |
1.01 |
1.04 |
.99 |
.96 |
.89 |
1.02 |
|
| Gpx7 |  |
NM_024198 |
glutathione peroxidase 7 (Gpx7), mRNA [NM_024198] |
KLA | .91 |
1.00 |
.95 |
.96 |
.87 |
.90 |
.83 |
| ATP | 1.00 |
1.07 |
1.06 |
1.07 |
.94 |
.93 |
.88 |
| KLA/ATP | .96 |
1.01 |
.95 |
.98 |
.82 |
.90 |
.86 |
|
| Hrasls3 |  |
AK052657 |
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] |
KLA | 4.07 |
4.01 |
2.57 |
2.26 |
1.94 |
1.66 |
1.10 |
| ATP | .93 |
.92 |
1.00 |
.96 |
.95 |
.99 |
1.08 |
| KLA/ATP | 3.36 |
2.63 |
1.76 |
1.26 |
1.41 |
1.22 |
1.27 |
|
| Hrasls3 | |
NM_139269 |
HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] |
KLA | 11.37 |
10.85 |
12.50 |
16.13 |
13.98 |
17.12 |
6.64 |
| ATP | .86 |
.78 |
.96 |
.89 |
.84 |
.99 |
1.03 |
| KLA/ATP | 8.90 |
10.50 |
15.81 |
13.10 |
11.95 |
11.16 |
10.19 |
|
| Lta4h |  |
NM_008517 |
leukotriene A4 hydrolase (Lta4h), mRNA [NM_008517] |
KLA | .84 |
.85 |
.77 |
.59 |
.48 |
.46 |
.63 |
| ATP | .99 |
1.20 |
1.11 |
1.29 |
1.02 |
.98 |
.83 |
| KLA/ATP | .86 |
.85 |
.72 |
.95 |
.72 |
.92 |
.59 |
|
| Ltc4s |  |
NM_008521 |
leukotriene C4 synthase (Ltc4s), mRNA [NM_008521] |
KLA | .96 |
.97 |
.92 |
.83 |
.62 |
.43 |
.13 |
| ATP | .94 |
.98 |
.97 |
1.09 |
.77 |
.51 |
.27 |
| KLA/ATP | .92 |
.89 |
.88 |
.81 |
.68 |
.49 |
.26 |
|
| Mm.1332 |  |
171543845 |
Unknown |
KLA | .95 |
.97 |
.87 |
.99 |
.98 |
.98 |
1.04 |
| ATP | 1.00 |
.93 |
1.00 |
1.08 |
.95 |
1.02 |
.92 |
| KLA/ATP | 1.03 |
1.12 |
.94 |
.98 |
1.01 |
.91 |
1.10 |
|
Mm.16006
7 |  |
124487226 |
Unknown |
KLA | .90 |
.88 |
.87 |
.85 |
.80 |
.85 |
.64 |
| ATP | .95 |
.95 |
1.00 |
.94 |
1.00 |
.91 |
.67 |
| KLA/ATP | .89 |
.86 |
.93 |
.82 |
.85 |
.84 |
.63 |
|
Mm.26915
|  |
51921286 |
Unknown |
KLA | 1.02 |
1.03 |
.96 |
1.11 |
1.05 |
.96 |
.96 |
| ATP | 1.02 |
1.00 |
.98 |
1.06 |
1.04 |
.99 |
1.08 |
| KLA/ATP | .96 |
.94 |
1.06 |
1.00 |
1.02 |
1.00 |
1.03 |
|
Mm.26940
|  |
113680351 |
Unknown |
KLA | .71 |
.71 |
.72 |
.65 |
.63 |
.83 |
.93 |
| ATP | .94 |
.87 |
1.23 |
1.30 |
1.21 |
1.41 |
1.76 |
| KLA/ATP | .70 |
.69 |
.89 |
.88 |
1.21 |
1.51 |
1.45 |
|
Mm.28967
2 |  |
133893229 |
Unknown |
KLA | 1.01 |
1.03 |
1.00 |
.97 |
.97 |
1.02 |
1.02 |
| ATP | .97 |
.98 |
.92 |
1.05 |
.98 |
.99 |
1.07 |
| KLA/ATP | .93 |
1.03 |
.95 |
.99 |
1.02 |
1.04 |
1.05 |
|
Mm.29467
8 |  |
124487254 |
Unknown |
KLA | 1.01 |
1.07 |
1.03 |
.98 |
1.02 |
1.09 |
1.02 |
| ATP | 1.02 |
1.00 |
1.02 |
1.08 |
.96 |
1.04 |
.97 |
| KLA/ATP | 1.01 |
1.00 |
1.05 |
1.05 |
1.01 |
1.06 |
1.01 |
|
Mm.33050
7 |  |
67906182 |
Unknown |
KLA | .94 |
.98 |
.99 |
1.03 |
1.05 |
1.07 |
.98 |
| ATP | .95 |
1.02 |
.97 |
.98 |
.99 |
1.05 |
1.02 |
| KLA/ATP | 1.02 |
1.05 |
1.01 |
1.03 |
.99 |
.98 |
.97 |
|
Mm.42607
7 |  |
58743309 |
Unknown |
KLA | .98 |
.93 |
1.04 |
1.03 |
.97 |
.98 |
1.16 |
| ATP | 1.02 |
.95 |
1.02 |
1.06 |
.96 |
.95 |
1.04 |
| KLA/ATP | .98 |
.97 |
.98 |
1.01 |
.99 |
1.11 |
.91 |
|
Mm.44829
2 |  |
86198313 |
Unknown |
KLA | 1.12 |
1.03 |
1.02 |
1.14 |
1.04 |
1.07 |
1.02 |
| ATP | .95 |
.98 |
1.18 |
1.06 |
1.12 |
1.07 |
1.04 |
| KLA/ATP | 1.04 |
1.15 |
1.29 |
1.11 |
1.16 |
1.21 |
1.14 |
|
Mm.46661
0 |  |
82894546 |
Unknown |
KLA | .86 |
.90 |
.99 |
.94 |
1.02 |
.83 |
.91 |
| ATP | 1.10 |
1.04 |
1.04 |
1.15 |
1.03 |
.93 |
.84 |
| KLA/ATP | .86 |
.85 |
1.00 |
1.10 |
.94 |
.85 |
.90 |
|
Mm.71913
|  |
118130231 |
Unknown |
KLA | .93 |
1.00 |
1.06 |
.97 |
.95 |
.98 |
1.04 |
| ATP | 1.00 |
.98 |
1.08 |
1.02 |
.92 |
.90 |
.99 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.99 |
.99 |
.99 |
1.01 |
|
| Pla2g10 |  |
NM_011987 |
phospholipase A2, group X (Pla2g10), mRNA [NM_011987] |
KLA | .99 |
1.11 |
1.02 |
.99 |
1.00 |
1.01 |
1.02 |
| ATP | 1.02 |
.97 |
1.01 |
1.03 |
1.00 |
1.02 |
1.04 |
| KLA/ATP | 1.04 |
.96 |
.95 |
1.04 |
1.06 |
1.05 |
1.01 |
|
Pla2g12a
|  |
NM_023196 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] |
KLA | 1.03 |
1.06 |
.97 |
1.00 |
.78 |
.75 |
.92 |
| ATP | .91 |
.99 |
1.29 |
1.30 |
1.20 |
1.48 |
1.71 |
| KLA/ATP | .92 |
.99 |
1.19 |
1.16 |
1.06 |
1.12 |
1.36 |
|
Pla2g12a
| |
NM_183423 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] |
KLA | .90 |
1.00 |
.87 |
.95 |
.76 |
.68 |
.88 |
| ATP | .96 |
.94 |
1.26 |
1.24 |
1.19 |
1.47 |
1.88 |
| KLA/ATP | .89 |
.90 |
1.08 |
1.07 |
1.06 |
1.02 |
1.59 |
|
Pla2g12b
|  |
NM_023530 |
phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] |
KLA | .98 |
.95 |
1.05 |
.99 |
1.03 |
.99 |
.94 |
| ATP | 1.02 |
1.04 |
1.07 |
1.05 |
.92 |
1.04 |
1.00 |
| KLA/ATP | .98 |
.92 |
1.10 |
1.11 |
1.09 |
1.03 |
1.04 |
|
| Pla2g1b |  |
NM_011107 |
phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] |
KLA | 1.00 |
1.01 |
1.01 |
1.11 |
1.00 |
1.28 |
1.00 |
| ATP | .98 |
1.03 |
1.09 |
1.03 |
1.01 |
1.02 |
1.04 |
| KLA/ATP | .93 |
.94 |
1.01 |
1.00 |
.94 |
1.09 |
1.07 |
|
| Pla2g2a |  |
NM_001082531 |
phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] |
KLA | 1.08 |
.99 |
1.00 |
1.06 |
.98 |
1.01 |
.94 |
| ATP | 1.07 |
.98 |
1.04 |
1.06 |
.90 |
.98 |
.98 |
| KLA/ATP | .98 |
1.03 |
1.00 |
1.04 |
.94 |
.97 |
.96 |
|
| Pla2g2c |  |
NM_008868 |
phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] |
KLA | .98 |
.99 |
1.05 |
.98 |
1.01 |
1.00 |
1.04 |
| ATP | 1.08 |
1.06 |
1.09 |
.93 |
.92 |
.92 |
1.00 |
| KLA/ATP | 1.03 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
1.02 |
|
| Pla2g2d |  |
NM_011109 |
phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] |
KLA | 1.02 |
1.02 |
.99 |
.99 |
1.00 |
1.01 |
1.00 |
| ATP | .95 |
1.11 |
1.10 |
1.11 |
.98 |
.99 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.19 |
1.11 |
1.00 |
.96 |
1.01 |
|
| Pla2g2e |  |
NM_012044 |
phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] |
KLA | .78 |
.75 |
.74 |
.72 |
.62 |
.69 |
1.40 |
| ATP | 1.06 |
1.00 |
.92 |
1.04 |
.83 |
.76 |
3.74 |
| KLA/ATP | .78 |
.80 |
.69 |
.74 |
.70 |
.74 |
2.24 |
|
| Pla2g2f |  |
NM_012045 |
phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] |
KLA | 1.02 |
.99 |
1.03 |
1.01 |
1.00 |
.95 |
.99 |
| ATP | 1.01 |
1.06 |
1.11 |
.97 |
1.09 |
1.11 |
.99 |
| KLA/ATP | 1.10 |
1.05 |
1.04 |
.95 |
1.04 |
1.01 |
.96 |
|
| Pla2g3 |  |
NM_172791 |
phospholipase A2, group III (Pla2g3), mRNA [NM_172791] |
KLA | 1.04 |
1.05 |
1.02 |
1.01 |
1.04 |
1.11 |
1.00 |
| ATP | .96 |
.97 |
1.10 |
.91 |
.99 |
.97 |
1.08 |
| KLA/ATP | 1.03 |
1.11 |
1.10 |
.98 |
.95 |
.98 |
1.07 |
|
| Pla2g4a |  |
NM_008869 |
phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] |
KLA | 3.93 |
4.49 |
4.86 |
6.40 |
6.44 |
3.10 |
1.68 |
| ATP | 1.13 |
1.36 |
1.27 |
1.30 |
1.02 |
5.37 |
1.47 |
| KLA/ATP | 3.64 |
4.45 |
4.76 |
7.11 |
2.96 |
4.08 |
2.60 |
|
| Pla2g4b |  |
NM_145378 |
phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] |
KLA | 1.09 |
1.18 |
.95 |
1.01 |
.97 |
.97 |
.77 |
| ATP | 1.05 |
1.14 |
1.28 |
.94 |
.88 |
1.18 |
.70 |
| KLA/ATP | 1.23 |
1.43 |
1.21 |
1.02 |
1.15 |
1.16 |
.78 |
|
| Pla2g4c |  |
AK145339 |
1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] |
KLA | 1.09 |
1.21 |
1.33 |
1.17 |
1.26 |
1.30 |
1.05 |
| ATP | .97 |
1.06 |
1.00 |
.98 |
.98 |
.98 |
1.05 |
| KLA/ATP | 1.19 |
1.16 |
1.18 |
1.13 |
1.04 |
1.02 |
1.06 |
|
| Pla2g4c | |
NM_001004762 |
phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] |
KLA | .93 |
1.00 |
.94 |
.93 |
.94 |
.94 |
.96 |
| ATP | .98 |
.96 |
1.13 |
.97 |
.99 |
.89 |
.96 |
| KLA/ATP | 1.01 |
1.01 |
1.07 |
1.01 |
.94 |
1.01 |
.92 |
|
| Pla2g4e |  |
AK049063 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] |
KLA | 1.03 |
1.09 |
1.01 |
1.01 |
1.06 |
.94 |
1.05 |
| ATP | 1.03 |
1.00 |
1.06 |
1.01 |
.96 |
1.05 |
1.05 |
| KLA/ATP | .98 |
1.00 |
1.01 |
.98 |
1.03 |
.95 |
1.01 |
|
| Pla2g4e | |
NM_177845 |
phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] |
KLA | .97 |
.95 |
1.01 |
.97 |
1.02 |
1.03 |
1.05 |
| ATP | .98 |
.99 |
1.00 |
1.10 |
.98 |
1.00 |
1.02 |
| KLA/ATP | 1.05 |
.93 |
.96 |
1.03 |
1.08 |
1.05 |
.99 |
|
| Pla2g4f |  |
NM_001024145 |
phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] |
KLA | 1.08 |
.99 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
| ATP | .99 |
1.04 |
.99 |
1.03 |
1.12 |
1.01 |
1.25 |
| KLA/ATP | .97 |
1.04 |
1.10 |
1.06 |
1.04 |
1.03 |
1.03 |
|
| Pla2g5 |  |
NM_011110 |
phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] |
KLA | .65 |
.62 |
.56 |
.53 |
.62 |
1.60 |
3.01 |
| ATP | .90 |
.82 |
.88 |
1.69 |
1.82 |
1.26 |
6.32 |
| KLA/ATP | .63 |
.59 |
.65 |
.63 |
.91 |
1.56 |
5.59 |
|
| Pla2g6 |  |
NM_016915 |
phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] |
KLA | .60 |
.59 |
.56 |
.60 |
.94 |
1.31 |
1.59 |
| ATP | 1.10 |
1.14 |
.95 |
1.05 |
1.06 |
1.13 |
1.14 |
| KLA/ATP | .63 |
.56 |
.54 |
.56 |
.71 |
.97 |
1.55 |
|
| Plb1 |  |
AK015993 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] |
KLA | .99 |
.99 |
1.05 |
1.02 |
1.03 |
1.07 |
1.02 |
| ATP | 1.04 |
1.03 |
1.07 |
1.06 |
1.09 |
1.01 |
1.02 |
| KLA/ATP | 1.07 |
1.00 |
.96 |
1.09 |
1.05 |
1.08 |
1.01 |
|
| Plb1 | |
AK087596 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] |
KLA | .93 |
.99 |
.99 |
1.07 |
.98 |
1.00 |
.98 |
| ATP | 1.08 |
1.00 |
.97 |
1.07 |
1.04 |
1.09 |
.96 |
| KLA/ATP | 1.06 |
.96 |
1.00 |
.98 |
1.04 |
1.06 |
.98 |
|
| Plb1 | |
NM_001081407 |
phospholipase B1 (Plb1), mRNA [NM_001081407] |
KLA | 1.05 |
1.09 |
1.05 |
1.04 |
1.05 |
1.03 |
.85 |
| ATP | .96 |
1.03 |
1.02 |
.95 |
1.06 |
1.01 |
.92 |
| KLA/ATP | 1.00 |
1.00 |
1.09 |
1.00 |
.97 |
.99 |
.86 |
|
| Ptgds |  |
NM_008963 |
prostaglandin D2 synthase (brain) (Ptgds), mRNA [NM_008963] |
KLA | 1.19 |
1.16 |
1.11 |
1.19 |
1.04 |
.98 |
.93 |
| ATP | .99 |
.99 |
1.10 |
1.07 |
1.02 |
1.00 |
.97 |
| KLA/ATP | 1.18 |
1.18 |
1.31 |
1.39 |
1.09 |
.89 |
.90 |
|
| Ptgds2 |  |
NM_019455 |
prostaglandin D2 synthase 2, hematopoietic (Ptgds2), mRNA [NM_019455] |
KLA | .50 |
.48 |
.58 |
.52 |
.66 |
.57 |
.53 |
| ATP | 1.03 |
1.05 |
1.05 |
1.36 |
1.04 |
.32 |
.61 |
| KLA/ATP | .52 |
.47 |
.50 |
.74 |
.73 |
.35 |
.42 |
|
| Ptges |  |
NM_022415 |
prostaglandin E synthase (Ptges), mRNA [NM_022415] |
KLA | 16.01 |
15.00 |
16.36 |
20.05 |
28.20 |
32.79 |
23.08 |
| ATP | 1.00 |
1.03 |
1.44 |
2.27 |
10.67 |
30.61 |
17.52 |
| KLA/ATP | 14.56 |
16.98 |
20.33 |
21.07 |
21.87 |
25.39 |
38.01 |
|
| Ptges2 |  |
NM_133783 |
prostaglandin E synthase 2 (Ptges2), mRNA [NM_133783] |
KLA | 1.02 |
1.07 |
1.30 |
1.30 |
1.39 |
1.06 |
1.43 |
| ATP | 1.09 |
1.14 |
.97 |
1.09 |
.70 |
1.00 |
1.20 |
| KLA/ATP | 1.19 |
1.12 |
.93 |
1.13 |
.81 |
.97 |
1.37 |
|
| Ptges3 |  |
NM_019766 |
prostaglandin E synthase 3 (cytosolic) (Ptges3), mRNA [NM_019766] |
KLA | 1.26 |
1.26 |
1.19 |
1.10 |
1.10 |
1.01 |
1.20 |
| ATP | 1.08 |
1.21 |
1.14 |
1.68 |
1.49 |
1.49 |
.65 |
| KLA/ATP | 1.31 |
1.49 |
1.19 |
1.74 |
1.34 |
1.12 |
.78 |
|
| Ptgis |  |
NM_008968 |
prostaglandin I2 (prostacyclin) synthase (Ptgis), mRNA [NM_008968] |
KLA | 1.05 |
1.07 |
.93 |
1.05 |
1.05 |
1.05 |
1.02 |
| ATP | 1.01 |
.98 |
1.01 |
1.04 |
1.02 |
.92 |
1.00 |
| KLA/ATP | 1.09 |
.99 |
.94 |
.99 |
.96 |
1.01 |
1.06 |
|
| Ptgs1 |  |
NM_008969 |
prostaglandin-endoperoxide synthase 1 (Ptgs1), mRNA [NM_008969] |
KLA | .74 |
.74 |
.76 |
.74 |
.61 |
.53 |
.18 |
| ATP | 1.01 |
1.05 |
1.29 |
1.14 |
.99 |
1.16 |
3.96 |
| KLA/ATP | .77 |
.71 |
.88 |
.77 |
.75 |
.61 |
.40 |
|
| Ptgs2 |  |
NM_011198 |
prostaglandin-endoperoxide synthase 2 (Ptgs2), mRNA [NM_011198] |
KLA | 181.04 |
220.88 |
218.58 |
132.79 |
103.05 |
22.69 |
18.02 |
| ATP | 2.47 |
9.45 |
52.13 |
208.62 |
271.22 |
306.11 |
6.86 |
| KLA/ATP | 233.39 |
387.29 |
617.86 |
###.## |
608.44 |
290.80 |
112.22 |
|
| Tbxas1 |  |
AK048544 |
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130072B09 product:thromboxane A synthase 1, platelet, full insert sequence. [AK048544] |
KLA | .96 |
.96 |
1.09 |
1.03 |
.96 |
1.02 |
.96 |
| ATP | 1.02 |
.96 |
.99 |
.97 |
.94 |
.95 |
1.51 |
| KLA/ATP | .97 |
.97 |
.95 |
.95 |
.92 |
.96 |
1.30 |
|
| Tbxas1 | |
NM_011539 |
thromboxane A synthase 1, platelet (Tbxas1), mRNA [NM_011539] |
KLA | .62 |
.62 |
.66 |
.58 |
.64 |
.76 |
.74 |
| ATP | 1.12 |
1.08 |
.92 |
.94 |
.74 |
.42 |
.68 |
| KLA/ATP | .69 |
.73 |
.61 |
.62 |
.42 |
.33 |
.51 |
|
: View data/graphs for replicates
ATP
ATP+KLA